Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

First patient recruited for trial assessing whether the nail should be replaced or discarded after nail bed repair in children.

The Plastic and Hand Surgery community are working to develop a research portfolio and to improve the evidence used to guide their clinical practice. The first ever multi-centre plastic surgery trial run by the Reconstructive Surgery Trials Network is currently being led by our very own Associate Professor Abhilash Jain and coordinated by SITU, in NDORMS.  

The NINJA Pilot Study (funded by the British Society for Surgery of the Hand, BSSH) is a pragmatic multicentre study to assess whether the nail should be replaced or discarded after nail bed repair in children. The pilot will inform the design and conduct of a larger NINJA study with regards to recruitment, data collection and outcome measurement.

On Tuesday 21 April 2015, the first patient was recruited to the trial. The study team participating in the study in Hull, East Yorkshire beat their colleagues in Oxford, Guys & St Thomas' (London) and in Broomfield (Essex), to become the first centre to randomise a patient. All four sites involved in the trial are enthusiastic and have set up local procedures in attempts to capture appropriate patients and optimise recruitment.

NINJA Chief Investigator, Associate Professor Jain says: “This is the first Plastic and Hand Surgery trial to be run by the Reconstructive Surgery Trials Network, which was recently set up to deliver clinical research for both the association of Plastic Surgery (BAPRAS) and the association of Hand Surgery (BSSH). This represents a small but significant step forward for reconstructive surgery within the UK.”

As NINJA progresses we are also in the process of developing another trial for the plastics and hand surgery research portfolio. INDICATE will assess management options for patients with carpal tunnel syndrome and we hope to get started with a pilot study for this trial in the summer.

For further information about NINJA please go here.

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.